← Browse by Condition
Medical Condition
metastatic pancreatic ductal adenocarcinoma
Total Trials
5
Recruiting Now
5
Trial Phases
Phase 1, Phase 2, Phase 2, EARLY_Phase 1
NCT07214298 Phase 1, Phase 2
Recruiting
Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma
Enrollment
35 pts
Location
United States
Sponsor
Roswell Park Cancer Institute
NCT06843551 Phase 2
Recruiting
The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation
Enrollment
20 pts
Location
United States
Sponsor
Benjamin Spieler
NCT04005690 EARLY_Phase 1
Recruiting
Targeted Pathway Inhibition in Patients With Pancreatic Cancer
Enrollment
90 pts
Location
United States
Sponsor
OHSU Knight Cancer Institute
NCT06445062 Phase 1, Phase 2
Recruiting
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Enrollment
1,130 pts
Location
United States
Sponsor
Revolution Medicines, Inc.
NCT07096362 Phase 2
Recruiting
Utility of ctDNA in Early Switch of First-line mFOLFIRINOX in Metastatic Pancreatic Ductal Adenocarcinoma
Enrollment
50 pts
Location
United States
Sponsor
University of Miami